droxidopa has been researched along with Atrophy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, Y; Konagaya, M; Konishi, T; Matsuoka, Y | 1 |
| Kaufmann, H; Oribe, E; Yahr, MD | 1 |
| Kishimoto, S; Sakoda, S; Suzuki, T; Ueji, M | 1 |
3 other study(ies) available for droxidopa and Atrophy
| Article | Year |
|---|---|
[Malignant syndrome in multiple system atrophy].
Topics: Adult; Aged; Antidepressive Agents; Antiparkinson Agents; Atrophy; Basal Ganglia Diseases; Corpus Striatum; Droxidopa; Female; Humans; Male; Middle Aged; Neuroleptic Malignant Syndrome; Spinocerebellar Degenerations; Substantia Nigra | 1997 |
Differential effect of L-threo-3,4-dihydroxyphenylserine in pure autonomic failure and multiple system atrophy with autonomic failure.
Topics: Adult; Aged; Atrophy; Autonomic Nervous System Diseases; Blood Pressure; Droxidopa; Humans; Hypotension, Orthostatic; Kinetics; Middle Aged; Norepinephrine; Supine Position | 1991 |
Mass spectrometric measurements of norepinephrine synthesis in man from infusion of stable isotope-labelled L-threo-3,4-dihydroxyphenylserine.
Topics: Atrophy; Brain Diseases; Cerebellum; Droxidopa; Gas Chromatography-Mass Spectrometry; Humans; Hypotension, Orthostatic; Norepinephrine; Olivary Nucleus; Parkinson Disease; Pons; Serine | 1985 |